New Delhi, Aug. 25 -- Two Indian drugmakers have filed lawsuits against Danish drugmaker Novo Nordisk over its blockbuster weight-loss drug semaglutide, which is set to lose its patent in India in Mar... Read More
New Delhi, Aug. 22 -- Apollo Hospitals Enterprises Ltd's managing director Suneeta Reddy offloaded a partial stake in the company on Friday via a block deal to pare the promoter group's outstanding de... Read More
New Delhi, Aug. 21 -- If you are someone with genetic or lifestyle factors putting you at risk of heart disease, diabetes or cancer, chances are you get an annual blood check-up done regularly. Five y... Read More
New Delhi, Aug. 21 -- Suneeta Reddy, managing director of Apollo Hospitals Enterprises Ltd (AHEL) and a member of the promoter family, is set to offload a partial stake in the company through one or m... Read More
New Delhi, Aug. 14 -- A six-year-old's death in Delhi recently due to a dog bite prompted a Supreme Court directive that has sparked widespread furore. On Monday, the apex court directed municipal au... Read More
MUMBAI, Aug. 13 -- Eli Lilly has stepped up its fight with Novo Nordisk in India's fast-growing anti-obesity market, launching a prefilled pen version of its blockbuster weight-loss drug Mounjaro at t... Read More
New Delhi, Aug. 12 -- Apollo Hospitals Enterprise Ltd (Ahel) is stepping up its medical tourism strategy, aiming to diversify its overseas patient base beyond Bangladesh, where inflows have slowed due... Read More
New Delhi, Aug. 12 -- Zydus Lifesciences beat Street estimates in the June quarter on the back of steady India growth, a stronger US portfolio, and surging international sales. This sets the stage for... Read More
New Delhi, Aug. 9 -- Biocon Biologics Ltd, the biosimilars unit of biopharmaceutical giant Biocon and its largest revenue driver, expects to accelerate growth after reporting a strong first quarter, a... Read More
New Delhi, Aug. 7 -- Biocon posted its financial results for the quarter ending 30 June with its revenue from operations up 15% year-on-year at Rs.3,942 crore, driven by gains in its biosimilars and C... Read More